NCT06771648Completed
Daxxin Psoriasis Shampoo PMCF
A Prospective, Single-arm, Open-label, Post-market Clinical Follow-up Investigation to Verify Performance and Safety of Daxxin Psoriasis Shampoo When Used for Treatment of Moderate Scalp Psoriasis
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
The goal of this clinical investigation is to verify the performance and safety of the CE-marked Daxxin Psoriasis Shampoo to treat scalp psoriasis. Forty-one subjects with moderate scalp psoriasis are planned to be recruited at one site in Sweden. Subjects will be asked to use the shampoo between 3 and 7 times a week, as per the instructions for use from the manufacturer, for a period of 6 weeks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 41 (actual)
- First submitted
- 19 Dec 2024
- Start date
- 24 Feb 2025
- Primary completion date
- 19 Dec 2025
- Lead sponsor
- Daxxin AB
- Diseases
- Psoriasis
- NCT number
- NCT06771648
What you commit to
- Study type: Interventional
- Participants enrolled: 41
- From 24 Feb 2025 to the primary completion date, 19 Dec 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of psoriasis shampoo 2 weeks prior to enrolment
- Use of other psoriasis scalp treatment i.e., Betnovate that could affect the study result within 4 weeks prior to enrolment
- Subject with alcohol or drug abuse
Other illness
- Known allergy or sensitivity to any component of the device
- Subject has a history of psoriasis unresponsive to topical treatments
- Subjects with any other condition that, as judged by the investigator, may make investigation procedures inappropriate
Other
- Use of systemic and/or biological treatment for psoriasis
- Subject is pregnant, lactating at time of enrolment, or is planning to become pregnant during the study
Who the study is looking for
- Male or female ≥18 years old
- Clinical diagnosis of moderate scalp psoriasis assessed by Psoriasis Scalp Severity Index (PSSI, moderate = 3-10)
- At least a score of 1 grade for each symptom erythema, induration and desquamation
- Subject is willing and able to use Daxxin Psoriasis Shampoo as directed, comply with investigation instructions, and commit to all follow-up visits for the duration of the investigation, as judged by the Investigator
- Subject agrees to refrain from using other treatments for scalp psoriasis during the clinical investigation
- Subject is willing and able to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CTC Coordinator of this site? Confirm its status | Mölndal | Sweden | Unknown status |
| Enheten för kliniska studier, University Hospital Region Örebro Coordinator of this site? Confirm its status | Örebro | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.